Structural and functional neuroimaging studies of the suicidal brain

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 4, 2011, Pages 796-808

  Desmyter, S ^a   van Heeringen, C ^a,b   Audenaert, K ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Functional Magnetic Resonance Imaging (fMRI); Magnetic Resonance Imaging (MRI); Neuroimaging; Positron Emission Tomography (PET); Single Photon Emission Computed Tomography (SPECT); Suicidal behavior

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID CARRIER; 5 HYDROXYINDOLEACETIC ACID; CARBON 11; DEXFENFLURAMINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; FENFLURAMINE; FLUMAZENIL; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NORADRENALIN; PLACEBO; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

AGGRESSIVENESS; AMYGDALOID NUCLEUS; ANATOMICAL VARIATION; AUTOMUTILATION; BIPOLAR DEPRESSION; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN SIZE; BRAIN VENTRICLE; CEREBELLUM; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CORPUS CALLOSUM; ECHOENCEPHALOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPULSIVENESS; INSULA; LATERAL BRAIN VENTRICLE; LETHALITY; MAJOR DEPRESSION; MESENCEPHALON; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PARAHIPPOCAMPAL GYRUS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CINGULATE; PREFRONTAL CORTEX; PREMOTOR CORTEX; PRIMARY MOTOR CORTEX; PROTEIN BINDING; PROVOCATION TEST; PUTAMEN; RAPHE NUCLEUS; SELF POISONING; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; UNCUS; VENTROMEDIAL PREFRONTAL CORTEX; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ANIMALS; BRAIN; COGNITION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SUICIDE; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 79955989172     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.12.026     Document Type: Short Survey

References (81)

1. Aguilar E.J., García-Martí G., Martí-Bonmatí L., Lull J.J., Moratal D., Escartí M.J., et al. Left orbitofrontal and superior temporal gyrus structural changes associated to suicidal behavior in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(7):1673-1676. Oct 1, Epub 2008 Jul 11.
2. Ahearn E.P., Jamison K.R., Steffens D.C., Cassidy F., Provenzale J.M., Lehman A., et al. MRI correlates of suicide attempt history in unipolar depression. Biol Psychiatry 2001, 50(4):266-270. Aug 15.
3. Amen D., Prunella J.R., Fallon J.H., Amen B., Hanks C. A comparative analysis of completed suicide using high resolution brain SPECT imaging. J Neuropsychiatry Clin Neurosci 2009, 21(4):430-439. Fall.
4. Arranz B., Eriksson A., Mellerup E., Plenge P., Marcusson J. Brain 5HT1A, 5HT1D, and 5HT2 receptors in suicide victims. Biol Psychiatry 1994, 35:457-463.
5. Asberg M., Träskman L., Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Arch Gen Psychiatry 1976, 33(10):1193-1197. Oct.
6. Audenaert K., Van Laere K., Dumont F., Slegers G., Mertens J., van Heeringen C., et al. Decreased frontal serotonin 5-HT2A receptor binding index in deliberate self-harm patients. Eur J Nucl Med 2001, 28(2):175-182. Feb.
7. Audenaert K., Goethals I., Van Laere K., Lahorte P., Brans B., Versijpt J., et al. SPECT neuropsychological activation procedure with the verbal fluency test in attempted suicide patients. Nucl Med Commun 2002, 23(9):907-916. Sep.
8. Audenaert K., Peremans K., Goethals I., van Heeringen C. Functional imaging, serotonin and the suicidal brain. Acta Neurol Belg 2006, 106(3):125-131. Review.
9. Bhagwagar Z., Rabiner E.A., Sargent P.A., Grasby P.M., Cowen P.J. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 2004, 9:386-392.
10. Biver F., Wikler D., Lotstra F., Damhaut P., Goldman S., Mendlewicz J. Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex. Br J Psychiatry 1997, 171:444-448. Nov.
11. Budisic M., Karlovic D., Trkanjec Z., Lovrencic-Huzjan A., Vukovic V., Bosnjak J., et al. Brainstem raphe lesion in patients with major depressive disorder and in patients with suicidal ideation recorded on transcranial sonography. Eur Arch Psychiatry Clin Neurosci 2010, 260(3):203-208. Apr, Epub 2009 Sep 15.
12. Cannon D.M., Klaver J.M., Peck S.A., Rallis-Voak D., Erickson K., Drevets W.C. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology 2009, 34(5):1277-1287. Apr, Epub 2008 Oct 22.
13. Caplan R., Siddarth P., Levitt J., Gurbani S., Shields W.D., Sankar R. Suicidality and brain volumes in pediatric epilepsy. Epilepsy Behav 2010, 18(3):286-290. Epub 2010 May 21.
14. Correa H., Duval F., Mokrani M., Bailey P., Trémeau F., Staner L., et al. Prolactin response to d-fenfluramine and suicidal behavior in depressed patients. Psychiatry Res 2000, 93(3):189-199. Apr 10.
15. Dougherty D.D., Bonab A.A., Ottowitz W.E., Livni E., Alpert N.M., Rauch S.L., et al. Decreased striatal D1 binding as measured using PET and [11C]SCH 23, 390 in patients with major depression with anger attacks. Depress Anxiety 2006, 23(3):175-177.
16. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999, 46(10):1375-1387. Nov 15.
17. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Greer P.J., Mathis C. Serotonin type-1A receptor imaging in depression. Nucl Med Biol 2000, 27:499-507.
18. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., et al. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 2007, 34(7):865-877. Oct.
19. Ehrlich S., Noam G.G., Lyoo I.K., Kwon B.J., Clark M.A., Renshaw P.F. Subanalysis of the location of white matter hyperintensities and their association with suicidality in children and youth. Ann NY Acad Sci 2003, 1008:265-268. Dec.
20. Ehrlich S., Breeze J.L., Hesdorffer D.C., Noam G.G., Hong X., Alban R.L., et al. White matter hyperintensities and their association with suicidality in depressed young adults. J Affect Disord 2005, 86(2-3):281-287. Jun.
21. Frankle W.G., Lombardo I., New A.S., Goodman M., Talbot P.S., Huang Y., et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 2005, 162(5):915-923. May.
22. Goethals I., Audenaert K., Jacobs F., Van den Eynde F., Bernagie K., Kolindou A., et al. Brain perfusion SPECT in impulsivity-related personality disorders. Behav Brain Res 2005, 157(1):187-192. Feb 10.
23. Goethals I., Audenaert K., Jacobs F., Van de Wiele C., Ham H., Pyck H., et al. Blunted prefrontal perfusion in depressed patients performing the Tower of London task. Psychiatry Res 2005, 139(1):31-40. May 30.
24. Hirvonen J., Karlsson H., Kajander J., Lepola A., Markkula J., Rasi-Hakala H., et al. Decreased brain serotonin 5-HT1A receptor availability in medicationnaive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 2008, 11:465-476.
25. Hwang J.P., Lee T.W., Tsai S.J., Chen T.J., Yang C.H., Lirng J.F., et al. Cortical and subcortical abnormalities in late-onset depression with history of suicide attempts investigated with MRI and voxel-based morphometry. J Geriatr Psychiatry Neurol 2010, Apr 29. [Epub ahead of print].
26. Ichimiya T., Suhara T., Sudo Y., Okubo Y., Nakayama K., Nankai M., et al. Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652. Biol Psychiatry 2002, 51(9):715-722. May 1.
27. Johnstone E.C., Crow T.J., Frith C.D., Husband J., Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976, 2(7992):924-926. Oct 30.
28. Jollant F., Lawrence N.S., Giampietro V., Brammer M.J., Fullana M.A., Drapier D., et al. Orbitofrontal cortex response to angry faces in men with histories of suicide attempts. Am J Psychiatry 2008, 165(6):740-748. Jun, Epub 2008 Mar 17.
29. Jollant F., Lawrence N.S., Olie E., O'Daly O., Malafosse A., Courtet P., et al. Decreased activation of lateral orbitofrontal cortex during risky choices under uncertainty is associated with disadvantageous decision-making and suicidal behavior. Neuroimage 2010, 51(3):1275-1281. Jul 1, Epub 2010 Mar 17.
30. Jovev M., Garner B., Phillips L., Velakoulis D., Wood S.J., Jackson H.J., et al. An MRI study of pituitary volume and parasuicidal behavior in teenagers with first-presentation borderline personality disorder. Psychiatry Res 2008, 162(3):273-277. Apr 15, Epub 2008 Mar 4.
31. Keilp J.G., Sackeim H.A., Brodsky B.S., Oquendo M.A., Malone K.M., Mann J.J. Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry 2001, 158(5):735-741. May.
32. Klumpers U.M., Veltman D.J., Drent M.L., Boellaard R., Comans E.F., Meynen G., et al. Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results. Eur J Nucl Med Mol Imaging 2010, 37(3):565-574. Mar, Epub 2009 Nov 5.
33. Koch W., Schaaff N., Pöpperl G., Mulert C., Juckel G., Reicherzer M., et al. [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. J Psychiatry Neurosci 2007, 32(4):234-240. Jul.
34. Kugaya A., Sanacora G., Verhoeff N.P., Fujita M., Mason G.F., Seneca N.M., et al. Cerebral benzodiazepine receptors in depressed patients measured with [123I]iomazenil SPECT. Biol Psychiatry 2003, 54(8):792-799. Oct 15.
35. Lehto S.M., Kuikka J., Tolmunen T., Hintikka J., Viinamäki H., Vanninen R., et al. Temporal cortex dopamine D2/3 receptor binding in major depression. Psychiatry Clin Neurosci 2008, 62(3):345-348. Jun.
36. Leyton M., Paquette V., Gravel P., Rosa-Neto P., Weston F., Diksic M., et al. Alpha-[11C]Methyl-l-tryptophan trapping in the orbital and ventral medial prefrontal cortex of suicide attempters. Eur Neuropsychopharmacol 2006, 16(3):220-223. Apr, Epub 2005 Nov 2.
37. Lindström M.B., Ryding E., Bosson P., Ahnlide J.A., Rosén I., Träskman-Bendz L. Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. Eur Neuropsychopharmacol 2004, 14(4):295-300. Aug.
38. Lopez O.L., Becker J.T., Reynolds C.F., Jungreis C.A., Weinman S., DeKosky S.T. Psychiatric correlates of MR deep white matter lesions in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1997, 9(2):246-250. Spring.
39. Lowther S., De Paermentier F., Crompton M.R., Katona C.L., Horton R.W. Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment. Brain Res 1994, 642(1-2):281-289. Apr 11.
40. Malone K.M., Corbitt E.M., Li S., Mann J.J. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 1996, 168(3):324-329. Mar.
41. Mann J.J., Malone K.M., Diehl D.J., Perel J., Cooper T.B., Mintun M.A. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 1996, 153(2):174-182. Feb.
42. Mann J.J. What does brain imaging tell us about the predisposition to suicidal behavior. Crisis 2005, 26(3):101-103.
43. Massou J.M., Trichard C., Attar-Levy D., Feline A., Corruble E., Beaufils B., et al. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology (Berl) 1997, 133(1):99-101. Sep.
44. Matsuo K., Nielsen N., Nicoletti M.A., Hatch J.P., Monkul E.S., Watanabe Y., et al. Anterior genu corpus callosum and impulsivity in suicidal patients with bipolar disorder. Neurosci Lett 2010, 469(1):75-80. Jan 18, Epub 2009 Nov 20.
45. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., et al. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 2004, 29:2258-2265.
46. Messa C., Colombo C., Moresco R.M., Gobbo C., Galli L., Lucignani G., et al. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berl) 2003, 167(1):72-78. Apr, Epub 2003 Mar 11.
47. Meyer J.H., Kennedy S., Brown G.M. No effect of depression on [(15)O]H2O PET response to intravenous d-fenfluramine. Am J Psychiatry 1998, 155(9):1241-1246. Sep.
48. Meyer J.H., Kapur S., Houle S., DaSilva J., Owczarek B., Brown G.M., et al. Prefrontal cortex 5-HT2 receptors in depression: an [18F] setoperone PET imaging study. Am J Psychiatry 1999, 156(7):1029-1034. Jul.
49. Meyer J.H., McMain S., Kennedy S.H., Korman L., Brown G.M., DaSilva J.N., et al. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry 2003, 160(1):90-99. Jan.
50. Meyer J.H., Houle S., Sagrati S., Carella A., Hussey D.F., Ginovart N., et al. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch Gen Psychiatry 2004, 61(12):1271-1279. Dec.
51. Monkul E.S., Hatch J.P., Nicoletti M.A., Spence S., Brambilla P., Lacerda A.L., et al. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry 2007, 12(4):360-366. Apr, Epub 2006 Dec 5.
52. Oquendo M.A., Placidi G.P., Malone K.M., Campbell C., Keilp J., Brodsky B., et al. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge and lethality of suicide attempts in major depression. Arch Gen Psychiatry 2003, 60(1):14-22. Jan.
53. Oquendo M.A., Hastings R.S., Huang Y.Y., Simpson N., Ogden R.T., Hu X.Z., et al. Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Arch Gen Psychiatry 2007, 64(2):201-208. Feb.
54. Owen F., Cross A., Crow T., Deakin JF., Ferrier IN., Lofthouse R., et al. Brain 5HT2 receptors and suicide. Lancet 1983, 2:1256.
55. Palmer A., Lowe S., Francis P., Bowen D. Are postmortem biochemical studies of human brain worthwhile?. Biochem Soc Trans 1988, 472-475.
56. Parsey R.V., Oquendo M.A., Simpson N.R., Ogden R.T., Van Heertum R., Arango V., et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 2002, 954(2):173-182. Nov 8.
57. Parsey R.V., Hastings R.S., Oquendo M.A., Huang Y.Y., Simpson N., Arcement J., et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006, 163(1):52-58. Jan.
58. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y.Y., et al. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 2006, 59:106-113.
59. Parsey R.V., Ogden R.T., Miller J.M., Tin A., Hesselgrave N., Goldstein E., et al. Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations. Biol Psychiatry 2010, 68(2):170-178. Jul 15, Epub 2010 May 23.
60. Pompili M., Innamorati M., Mann J.J., Oquendo M.A., Lester D., Del Casale A., et al. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(6):1501-1507. Aug 1, Epub 2008 May 20.
61. Reisch T., Seifritz E., Esposito F., Wiest R., Valach L., Michel K. An fMRI study on mental pain and suicidal behavior. J Affect Disord 2010, Oct;126(1-2):321-325. Apr 30.
62. Rüsch N., Spoletini I., Wilke M., Martinotti G., Bria P., Trequattrini A., et al. Inferior frontal white matter volume and suicidality in schizophrenia. Psychiatry Res 2008, 164(3):206-214. Dec 30, Epub 2008 Nov 13.
63. Ryding E., Ahnlide J.A., Lindström M., Rosén I., Träskman-Bendz L. Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res 2006, 148(2-3):195-203. Dec 1, Epub 2006 Nov 7.
64. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 2000, 57(2):174-180. Feb.
65. Schlegel S., Maier W., Philipp M., Aldenhoff J.B., Heuser I., Kretzschmar K., et al. Computed tomography in depression: association between ventricular size and psychopathology. Psychiatry Res 1989, 29(2):221-230. Aug.
66. Shively C.A., Friedman D.P., Gage H.D., Bounds M.C., Brown-Proctor C., Blair J.B., et al. Behavioral depression and positron emission tomography-determined serotonin 1A receptor binding potential in cynomolgus monkeys. Arch Gen Psychiatry 2006, 63:396-403.
67. Siever L.J., Buchsbaum M.S., New A.S., Spiegel-Cohen J., Wei T., Hazlett E.A., et al. d, 1-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose Positron Emission Tomography. Neuropsychopharmacology 1999, 20:413-423.
68. Soloff P.H., Meltzer C.C., Greer P.J., Constantine D., Kelly T.M. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry 2000, 47:540-547.
69. Soloff P.H., Meltzer C.C., Becker C., Greer P.J., Kelly T.M., Constantine D. Impulsivity and prefrontal hypometabolism in borderline personality disorder. Psychiatry Res 2003, 123(3):153-163. Jul 30.
70. Soloff P.H., Kelly T.M., Strotmeyer S.J., Malone K.M., Mann J.J. Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder. Psychiatry Res 2003, 119(1-2):11-24. Jul 15.
71. Soloff P., Nutche J., Goradia D., Diwadkar V. Structural brain abnormalities in borderline personality disorder: a voxel-based morphometry study. Psychiatry Res 2008, 164(3):223-236. Dec 30.
72. Soloff P.H., Price J.C., Mason N.S., Becker C., Meltzer C.C. Gender, personality, and serotonin-2A receptor binding in healthy subjects. Psychiatry Res 2010, 181(1):77-84. Jan 30, Epub.
73. Tiihonen J., Kuikka J., Bergström K., Hakola P., Karhu J., Ryynänen O.P., et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nat Med 1995, 1(7):654-657. Jul.
74. Tiihonen J., Kuikka J.T., Bergström K.A., Karhu J., Viinamäki H., Lehtonen J., et al. Single-photon emission tomography imaging of monoamine transporters in impulsive violent behaviour. Eur J Nucl Med 1997, 24(10):1253-1260. Oct.
75. Tiihonen J., Keski-Rahkonen A., Löppönen M., Muhonen M., Kajander J., Allonen T., et al. Brain serotonin 1A receptor binding in bulimia nervosa. Biol Psychiatry 2004, 55(8):871-873. Apr 15.
76. van Heeringen C., Audenaert K., Van Laere K., Dumont F., Slegers G., Mertens J., et al. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J Affect Disord 2003, 74(2):149-158. Apr.
77. van Heeringen K., Van den Abbeele D., Vervaet M., Soenen L., Audenaert K. The functional neuroanatomy of mental pain in depression. Psychiatry Res 2010, 181(2):141-144. Feb. 28, Epub 2010 Jan 13.
78. World Health Organisation (WHO) Statement 10 September World Suicide Prevention Day 2008. Around one million people die each year by suicide 2008.
79. Witte A.V., Flöel A., Stein P., Savli M., Mien L.K., Wadsak W., et al. Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum Brain Mapp 2009, 30(8):2558-2570. Aug, Erratum in: Hum Brain Mapp. 2010 Feb;31(2):339.
80. Yatham L.N., Liddle P.F., Shiah I.S., Scarrow G., Lam R.W., Adam M.J., et al. Brain serotonin2 receptors in major depression: a positron emission tomography study. Arch Gen Psychiatry 2000, 57(9):850-858. Sep.
81. Zanardi R., Artigas F., Moresco R., Colombo C., Messa C., Gobbo C., et al. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol 2001, 21(1):53-58. Feb.